Cases (n = 316) | Controls (n = 632) | P value | |
---|---|---|---|
Baseline data | |||
Age, year, mean (SD) | 64 (15.3) | 63 (16.0) | 0.34 |
Female sex, n (%) | 96 (30.4) | 227 (35.9) | 0.11 |
Body Mass Index, mean (SD) | 27.3 (6.1) | 27.2 (6.0) | 0.97 |
Charlson comorbidity index, median (IQR) | 3 (2–5) | 3 (2–5) | 0.98 |
Origin prior to ICU admission, n (%) | 0.56 | ||
Home | 173 (54.7) | 326 (51.6) | |
General ward | 86 (27.2) | 178 (28.2) | |
Long term facility | 7 (2.2) | 14 (2.2) | |
Other ICU | 39 (12.3) | 97 (15.3) | |
Primary reason for ICU admission, n (%) | 0.07 | ||
Medical | 166 (52.5) | 292 (46.2) | |
Surgical, cardiothoracic | 11 (3.5) | 44 (7.0) | |
Surgical, other | 75 (23.7) | 171 (27.1) | |
Trauma | 64 (20.3) | 125 (19.8) | |
Colonized with Staphylococcus aureus on admission, n (%) | 172 (54.4) | 316 (50.0) | 0.22 |
Pneumonia on ICU admission, n (%) | 75 (23.7) | 124 (19.6) | 0.17 |
APACHE IV, mean (SD) | 75 (37.1) | 70 (38.0) | 0.07 |
Laboratory values at ICU admissiona | |||
White blood cells, 109/L, median (IQR) | 12.6 (8.6–18.1) | 13.0 (9.2–17.5) | 0.54 |
Neutrophils, 109/L, median (IQR) | 10.8 (7.1–15.1) | 11.0 (7.2–15.2) | 0.85 |
Monocytes, 109/L, median (IQR) | 0.7 (0.4–1.0) | 0.7 (0.4–1.1) | 0.74 |
Lymphocytes, 109/L, median (IQR) | 0.8 (0.5–1.2) | 0.8 (0.5–1.3) | 0.97 |
Platelets, 109/L, median (IQR) | 199 (139–266) | 205 (148–271) | 0.34 |
Outcome data | |||
Length of ICU stay, days, median (IQR) | 15 (10–28) | 8 (5–14) | < 0.001 |
Readmission < 30 days of ICU discharge, n (%) | 16 (5.1) | 21 (3.3) | < 0.001 |
Status at Day 90 after ICU admission, n (%) | 0.02 | ||
Alive | 158 (53.6) | 368 (63.9) | |
Dead | 137 (46.4) | 208 (36.1) |